Clinical Epigenetics-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2105004, encodeId=0b7121050040b, content=巨慢，投稿系统还持续不稳定。佛系期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f81975964, createdName=1e170646m17(暂无匿称), createdTime=Thu Dec 08 22:58:06 CST 2022, time=2022-12-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1195827, encodeId=17c4119582ebc, content=我也来记录一下：2022.1.17 Submit；1.18 Reviewers Assigned 然后一个月状态纹丝不动，这真好慢啊，持续等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220221/0d3bc24c99254010b05063bc9bca3c80/6249f4ad5757491b815f6696fe3077c8.jpg, createdBy=011a4698295, createdName=1165291396, createdTime=Mon Feb 21 20:58:21 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196349, encodeId=5aad11963494f, content=审稿速度:6.0 经验分享：2021年投稿一篇，记录一下自己的投稿历程： 20210913投稿；20多天后从reviewers invited变成reviewers assigned；之后状态经历多轮reviewers invited, reviewers assigned, under review的变化，发邮件询问得到的回复是找不到reviewers；又过了很久，终于在20220203收到major revision的修改意见；20220208修改后返回杂志社；20220213 状态变成review completed；20220220 状态最终变成Final Decision Accept。 谨以此记录经验互享，祝福各位大神！山高水远，江湖再见～ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Feb 23 10:40:47 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566137, encodeId=487b56613e78, content=兄弟您好。我也是做的甲基化和临床相关的生存预后。能中吗？您是搞基础的吗zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, beContent=zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160801/IMG579F60E036DF66469.jpg, createdBy=8b2b1931040, createdName=南医草民, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196372, encodeId=a2b611963e2be, content=文章赶紧接受吧，祈祷🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=510d5710114, createdName=ms9000000046672090, createdTime=Wed Feb 23 11:48:09 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015027, encodeId=0b7d101502e83, content=请教一下，editor invited 代表什么进度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5df92471731, createdName=Zero2326, createdTime=Mon Sep 06 12:54:06 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056322, encodeId=17ce1056322b8, content=有大神知道editor invited 2个星期，没有变化是什么意思？是没有editor愿意审稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Sep 29 23:47:17 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587461, encodeId=051d58e461fc, content=2月28号提交修过的稿，现在还在editor assigned 救救孩子吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/28/5f700d89db881251d21146123e7612c7.jpg, createdBy=04bb2384617, createdName=1231e470m09(暂无昵称), createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976161, encodeId=474e9e616182, content=开始记录：5月22日投稿，6月1日变为Under Review，6月6日状态未变，状态日期变为6月6日, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Wed Jun 23 11:37:17 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995445, encodeId=2912995445f7, content=7月2日：Reviews Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Fri Jul 02 17:27:24 CST 2021, time=2021-07-02, status=1, ipAttribution=)]

2022-12-08 1e170646m17(暂无匿称) 来自湖北省

巨慢，投稿系统还持续不稳定。佛系期刊

46 0

[GetPortalCommentsPageByObjectIdResponse(id=2105004, encodeId=0b7121050040b, content=巨慢，投稿系统还持续不稳定。佛系期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f81975964, createdName=1e170646m17(暂无匿称), createdTime=Thu Dec 08 22:58:06 CST 2022, time=2022-12-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1195827, encodeId=17c4119582ebc, content=我也来记录一下：2022.1.17 Submit；1.18 Reviewers Assigned 然后一个月状态纹丝不动，这真好慢啊，持续等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220221/0d3bc24c99254010b05063bc9bca3c80/6249f4ad5757491b815f6696fe3077c8.jpg, createdBy=011a4698295, createdName=1165291396, createdTime=Mon Feb 21 20:58:21 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196349, encodeId=5aad11963494f, content=审稿速度:6.0 经验分享：2021年投稿一篇，记录一下自己的投稿历程： 20210913投稿；20多天后从reviewers invited变成reviewers assigned；之后状态经历多轮reviewers invited, reviewers assigned, under review的变化，发邮件询问得到的回复是找不到reviewers；又过了很久，终于在20220203收到major revision的修改意见；20220208修改后返回杂志社；20220213 状态变成review completed；20220220 状态最终变成Final Decision Accept。 谨以此记录经验互享，祝福各位大神！山高水远，江湖再见～ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Feb 23 10:40:47 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566137, encodeId=487b56613e78, content=兄弟您好。我也是做的甲基化和临床相关的生存预后。能中吗？您是搞基础的吗zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, beContent=zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160801/IMG579F60E036DF66469.jpg, createdBy=8b2b1931040, createdName=南医草民, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196372, encodeId=a2b611963e2be, content=文章赶紧接受吧，祈祷🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=510d5710114, createdName=ms9000000046672090, createdTime=Wed Feb 23 11:48:09 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015027, encodeId=0b7d101502e83, content=请教一下，editor invited 代表什么进度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5df92471731, createdName=Zero2326, createdTime=Mon Sep 06 12:54:06 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056322, encodeId=17ce1056322b8, content=有大神知道editor invited 2个星期，没有变化是什么意思？是没有editor愿意审稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Sep 29 23:47:17 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587461, encodeId=051d58e461fc, content=2月28号提交修过的稿，现在还在editor assigned 救救孩子吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/28/5f700d89db881251d21146123e7612c7.jpg, createdBy=04bb2384617, createdName=1231e470m09(暂无昵称), createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976161, encodeId=474e9e616182, content=开始记录：5月22日投稿，6月1日变为Under Review，6月6日状态未变，状态日期变为6月6日, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Wed Jun 23 11:37:17 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995445, encodeId=2912995445f7, content=7月2日：Reviews Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Fri Jul 02 17:27:24 CST 2021, time=2021-07-02, status=1, ipAttribution=)]

2022-02-21 1165291396

我也来记录一下：2022.1.17 Submit；1.18 Reviewers Assigned
然后一个月状态纹丝不动，这真好慢啊，持续等待中

94 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2105004, encodeId=0b7121050040b, content=巨慢，投稿系统还持续不稳定。佛系期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f81975964, createdName=1e170646m17(暂无匿称), createdTime=Thu Dec 08 22:58:06 CST 2022, time=2022-12-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1195827, encodeId=17c4119582ebc, content=我也来记录一下：2022.1.17 Submit；1.18 Reviewers Assigned 然后一个月状态纹丝不动，这真好慢啊，持续等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220221/0d3bc24c99254010b05063bc9bca3c80/6249f4ad5757491b815f6696fe3077c8.jpg, createdBy=011a4698295, createdName=1165291396, createdTime=Mon Feb 21 20:58:21 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196349, encodeId=5aad11963494f, content=审稿速度:6.0 经验分享：2021年投稿一篇，记录一下自己的投稿历程： 20210913投稿；20多天后从reviewers invited变成reviewers assigned；之后状态经历多轮reviewers invited, reviewers assigned, under review的变化，发邮件询问得到的回复是找不到reviewers；又过了很久，终于在20220203收到major revision的修改意见；20220208修改后返回杂志社；20220213 状态变成review completed；20220220 状态最终变成Final Decision Accept。 谨以此记录经验互享，祝福各位大神！山高水远，江湖再见～ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Feb 23 10:40:47 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566137, encodeId=487b56613e78, content=兄弟您好。我也是做的甲基化和临床相关的生存预后。能中吗？您是搞基础的吗zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, beContent=zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160801/IMG579F60E036DF66469.jpg, createdBy=8b2b1931040, createdName=南医草民, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196372, encodeId=a2b611963e2be, content=文章赶紧接受吧，祈祷🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=510d5710114, createdName=ms9000000046672090, createdTime=Wed Feb 23 11:48:09 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015027, encodeId=0b7d101502e83, content=请教一下，editor invited 代表什么进度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5df92471731, createdName=Zero2326, createdTime=Mon Sep 06 12:54:06 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056322, encodeId=17ce1056322b8, content=有大神知道editor invited 2个星期，没有变化是什么意思？是没有editor愿意审稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Sep 29 23:47:17 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587461, encodeId=051d58e461fc, content=2月28号提交修过的稿，现在还在editor assigned 救救孩子吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/28/5f700d89db881251d21146123e7612c7.jpg, createdBy=04bb2384617, createdName=1231e470m09(暂无昵称), createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976161, encodeId=474e9e616182, content=开始记录：5月22日投稿，6月1日变为Under Review，6月6日状态未变，状态日期变为6月6日, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Wed Jun 23 11:37:17 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995445, encodeId=2912995445f7, content=7月2日：Reviews Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Fri Jul 02 17:27:24 CST 2021, time=2021-07-02, status=1, ipAttribution=)]

2022-02-23 ms5000000155404164

审稿速度:6.0
经验分享：2021年投稿一篇，记录一下自己的投稿历程：
20210913投稿；20多天后从reviewers invited变成reviewers assigned；之后状态经历多轮reviewers invited, reviewers assigned, under review的变化，发邮件询问得到的回复是找不到reviewers；又过了很久，终于在20220203收到major revision的修改意见；20220208修改后返回杂志社；20220213 状态变成review completed；20220220 状态最终变成Final Decision Accept。
谨以此记录经验互享，祝福各位大神！山高水远，江湖再见～

77 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2105004, encodeId=0b7121050040b, content=巨慢，投稿系统还持续不稳定。佛系期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f81975964, createdName=1e170646m17(暂无匿称), createdTime=Thu Dec 08 22:58:06 CST 2022, time=2022-12-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1195827, encodeId=17c4119582ebc, content=我也来记录一下：2022.1.17 Submit；1.18 Reviewers Assigned 然后一个月状态纹丝不动，这真好慢啊，持续等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220221/0d3bc24c99254010b05063bc9bca3c80/6249f4ad5757491b815f6696fe3077c8.jpg, createdBy=011a4698295, createdName=1165291396, createdTime=Mon Feb 21 20:58:21 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196349, encodeId=5aad11963494f, content=审稿速度:6.0 经验分享：2021年投稿一篇，记录一下自己的投稿历程： 20210913投稿；20多天后从reviewers invited变成reviewers assigned；之后状态经历多轮reviewers invited, reviewers assigned, under review的变化，发邮件询问得到的回复是找不到reviewers；又过了很久，终于在20220203收到major revision的修改意见；20220208修改后返回杂志社；20220213 状态变成review completed；20220220 状态最终变成Final Decision Accept。 谨以此记录经验互享，祝福各位大神！山高水远，江湖再见～ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Feb 23 10:40:47 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566137, encodeId=487b56613e78, content=兄弟您好。我也是做的甲基化和临床相关的生存预后。能中吗？您是搞基础的吗zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, beContent=zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160801/IMG579F60E036DF66469.jpg, createdBy=8b2b1931040, createdName=南医草民, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196372, encodeId=a2b611963e2be, content=文章赶紧接受吧，祈祷🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=510d5710114, createdName=ms9000000046672090, createdTime=Wed Feb 23 11:48:09 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015027, encodeId=0b7d101502e83, content=请教一下，editor invited 代表什么进度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5df92471731, createdName=Zero2326, createdTime=Mon Sep 06 12:54:06 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056322, encodeId=17ce1056322b8, content=有大神知道editor invited 2个星期，没有变化是什么意思？是没有editor愿意审稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Sep 29 23:47:17 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587461, encodeId=051d58e461fc, content=2月28号提交修过的稿，现在还在editor assigned 救救孩子吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/28/5f700d89db881251d21146123e7612c7.jpg, createdBy=04bb2384617, createdName=1231e470m09(暂无昵称), createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976161, encodeId=474e9e616182, content=开始记录：5月22日投稿，6月1日变为Under Review，6月6日状态未变，状态日期变为6月6日, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Wed Jun 23 11:37:17 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995445, encodeId=2912995445f7, content=7月2日：Reviews Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Fri Jul 02 17:27:24 CST 2021, time=2021-07-02, status=1, ipAttribution=)]

2019-01-25 南医草民

兄弟您好。我也是做的甲基化和临床相关的生存预后。能中吗？您是搞基础的吗zhaoyang123 2019-01-20 00:00:00 发表:
文章接受，祝福各位大神，再见了。

zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。

183 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2105004, encodeId=0b7121050040b, content=巨慢，投稿系统还持续不稳定。佛系期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f81975964, createdName=1e170646m17(暂无匿称), createdTime=Thu Dec 08 22:58:06 CST 2022, time=2022-12-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1195827, encodeId=17c4119582ebc, content=我也来记录一下：2022.1.17 Submit；1.18 Reviewers Assigned 然后一个月状态纹丝不动，这真好慢啊，持续等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220221/0d3bc24c99254010b05063bc9bca3c80/6249f4ad5757491b815f6696fe3077c8.jpg, createdBy=011a4698295, createdName=1165291396, createdTime=Mon Feb 21 20:58:21 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196349, encodeId=5aad11963494f, content=审稿速度:6.0 经验分享：2021年投稿一篇，记录一下自己的投稿历程： 20210913投稿；20多天后从reviewers invited变成reviewers assigned；之后状态经历多轮reviewers invited, reviewers assigned, under review的变化，发邮件询问得到的回复是找不到reviewers；又过了很久，终于在20220203收到major revision的修改意见；20220208修改后返回杂志社；20220213 状态变成review completed；20220220 状态最终变成Final Decision Accept。 谨以此记录经验互享，祝福各位大神！山高水远，江湖再见～ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Feb 23 10:40:47 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566137, encodeId=487b56613e78, content=兄弟您好。我也是做的甲基化和临床相关的生存预后。能中吗？您是搞基础的吗zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, beContent=zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160801/IMG579F60E036DF66469.jpg, createdBy=8b2b1931040, createdName=南医草民, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196372, encodeId=a2b611963e2be, content=文章赶紧接受吧，祈祷🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=510d5710114, createdName=ms9000000046672090, createdTime=Wed Feb 23 11:48:09 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015027, encodeId=0b7d101502e83, content=请教一下，editor invited 代表什么进度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5df92471731, createdName=Zero2326, createdTime=Mon Sep 06 12:54:06 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056322, encodeId=17ce1056322b8, content=有大神知道editor invited 2个星期，没有变化是什么意思？是没有editor愿意审稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Sep 29 23:47:17 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587461, encodeId=051d58e461fc, content=2月28号提交修过的稿，现在还在editor assigned 救救孩子吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/28/5f700d89db881251d21146123e7612c7.jpg, createdBy=04bb2384617, createdName=1231e470m09(暂无昵称), createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976161, encodeId=474e9e616182, content=开始记录：5月22日投稿，6月1日变为Under Review，6月6日状态未变，状态日期变为6月6日, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Wed Jun 23 11:37:17 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995445, encodeId=2912995445f7, content=7月2日：Reviews Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Fri Jul 02 17:27:24 CST 2021, time=2021-07-02, status=1, ipAttribution=)]

2022-02-23 ms9000000046672090

文章赶紧接受吧，祈祷🙏

62 0

[GetPortalCommentsPageByObjectIdResponse(id=2105004, encodeId=0b7121050040b, content=巨慢，投稿系统还持续不稳定。佛系期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f81975964, createdName=1e170646m17(暂无匿称), createdTime=Thu Dec 08 22:58:06 CST 2022, time=2022-12-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1195827, encodeId=17c4119582ebc, content=我也来记录一下：2022.1.17 Submit；1.18 Reviewers Assigned 然后一个月状态纹丝不动，这真好慢啊，持续等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220221/0d3bc24c99254010b05063bc9bca3c80/6249f4ad5757491b815f6696fe3077c8.jpg, createdBy=011a4698295, createdName=1165291396, createdTime=Mon Feb 21 20:58:21 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196349, encodeId=5aad11963494f, content=审稿速度:6.0 经验分享：2021年投稿一篇，记录一下自己的投稿历程： 20210913投稿；20多天后从reviewers invited变成reviewers assigned；之后状态经历多轮reviewers invited, reviewers assigned, under review的变化，发邮件询问得到的回复是找不到reviewers；又过了很久，终于在20220203收到major revision的修改意见；20220208修改后返回杂志社；20220213 状态变成review completed；20220220 状态最终变成Final Decision Accept。 谨以此记录经验互享，祝福各位大神！山高水远，江湖再见～ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Feb 23 10:40:47 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566137, encodeId=487b56613e78, content=兄弟您好。我也是做的甲基化和临床相关的生存预后。能中吗？您是搞基础的吗zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, beContent=zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160801/IMG579F60E036DF66469.jpg, createdBy=8b2b1931040, createdName=南医草民, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196372, encodeId=a2b611963e2be, content=文章赶紧接受吧，祈祷🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=510d5710114, createdName=ms9000000046672090, createdTime=Wed Feb 23 11:48:09 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015027, encodeId=0b7d101502e83, content=请教一下，editor invited 代表什么进度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5df92471731, createdName=Zero2326, createdTime=Mon Sep 06 12:54:06 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056322, encodeId=17ce1056322b8, content=有大神知道editor invited 2个星期，没有变化是什么意思？是没有editor愿意审稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Sep 29 23:47:17 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587461, encodeId=051d58e461fc, content=2月28号提交修过的稿，现在还在editor assigned 救救孩子吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/28/5f700d89db881251d21146123e7612c7.jpg, createdBy=04bb2384617, createdName=1231e470m09(暂无昵称), createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976161, encodeId=474e9e616182, content=开始记录：5月22日投稿，6月1日变为Under Review，6月6日状态未变，状态日期变为6月6日, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Wed Jun 23 11:37:17 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995445, encodeId=2912995445f7, content=7月2日：Reviews Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Fri Jul 02 17:27:24 CST 2021, time=2021-07-02, status=1, ipAttribution=)]

2021-09-06 Zero2326

请教一下，editor invited 代表什么进度？

74 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2105004, encodeId=0b7121050040b, content=巨慢，投稿系统还持续不稳定。佛系期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f81975964, createdName=1e170646m17(暂无匿称), createdTime=Thu Dec 08 22:58:06 CST 2022, time=2022-12-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1195827, encodeId=17c4119582ebc, content=我也来记录一下：2022.1.17 Submit；1.18 Reviewers Assigned 然后一个月状态纹丝不动，这真好慢啊，持续等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220221/0d3bc24c99254010b05063bc9bca3c80/6249f4ad5757491b815f6696fe3077c8.jpg, createdBy=011a4698295, createdName=1165291396, createdTime=Mon Feb 21 20:58:21 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196349, encodeId=5aad11963494f, content=审稿速度:6.0 经验分享：2021年投稿一篇，记录一下自己的投稿历程： 20210913投稿；20多天后从reviewers invited变成reviewers assigned；之后状态经历多轮reviewers invited, reviewers assigned, under review的变化，发邮件询问得到的回复是找不到reviewers；又过了很久，终于在20220203收到major revision的修改意见；20220208修改后返回杂志社；20220213 状态变成review completed；20220220 状态最终变成Final Decision Accept。 谨以此记录经验互享，祝福各位大神！山高水远，江湖再见～ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Feb 23 10:40:47 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566137, encodeId=487b56613e78, content=兄弟您好。我也是做的甲基化和临床相关的生存预后。能中吗？您是搞基础的吗zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, beContent=zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160801/IMG579F60E036DF66469.jpg, createdBy=8b2b1931040, createdName=南医草民, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196372, encodeId=a2b611963e2be, content=文章赶紧接受吧，祈祷🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=510d5710114, createdName=ms9000000046672090, createdTime=Wed Feb 23 11:48:09 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015027, encodeId=0b7d101502e83, content=请教一下，editor invited 代表什么进度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5df92471731, createdName=Zero2326, createdTime=Mon Sep 06 12:54:06 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056322, encodeId=17ce1056322b8, content=有大神知道editor invited 2个星期，没有变化是什么意思？是没有editor愿意审稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Sep 29 23:47:17 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587461, encodeId=051d58e461fc, content=2月28号提交修过的稿，现在还在editor assigned 救救孩子吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/28/5f700d89db881251d21146123e7612c7.jpg, createdBy=04bb2384617, createdName=1231e470m09(暂无昵称), createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976161, encodeId=474e9e616182, content=开始记录：5月22日投稿，6月1日变为Under Review，6月6日状态未变，状态日期变为6月6日, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Wed Jun 23 11:37:17 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995445, encodeId=2912995445f7, content=7月2日：Reviews Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Fri Jul 02 17:27:24 CST 2021, time=2021-07-02, status=1, ipAttribution=)]

2021-09-29 ms5000000155404164

有大神知道editor invited 2个星期，没有变化是什么意思？是没有editor愿意审稿吗？

80 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2105004, encodeId=0b7121050040b, content=巨慢，投稿系统还持续不稳定。佛系期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f81975964, createdName=1e170646m17(暂无匿称), createdTime=Thu Dec 08 22:58:06 CST 2022, time=2022-12-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1195827, encodeId=17c4119582ebc, content=我也来记录一下：2022.1.17 Submit；1.18 Reviewers Assigned 然后一个月状态纹丝不动，这真好慢啊，持续等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220221/0d3bc24c99254010b05063bc9bca3c80/6249f4ad5757491b815f6696fe3077c8.jpg, createdBy=011a4698295, createdName=1165291396, createdTime=Mon Feb 21 20:58:21 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196349, encodeId=5aad11963494f, content=审稿速度:6.0 经验分享：2021年投稿一篇，记录一下自己的投稿历程： 20210913投稿；20多天后从reviewers invited变成reviewers assigned；之后状态经历多轮reviewers invited, reviewers assigned, under review的变化，发邮件询问得到的回复是找不到reviewers；又过了很久，终于在20220203收到major revision的修改意见；20220208修改后返回杂志社；20220213 状态变成review completed；20220220 状态最终变成Final Decision Accept。 谨以此记录经验互享，祝福各位大神！山高水远，江湖再见～ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Feb 23 10:40:47 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566137, encodeId=487b56613e78, content=兄弟您好。我也是做的甲基化和临床相关的生存预后。能中吗？您是搞基础的吗zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, beContent=zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160801/IMG579F60E036DF66469.jpg, createdBy=8b2b1931040, createdName=南医草民, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196372, encodeId=a2b611963e2be, content=文章赶紧接受吧，祈祷🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=510d5710114, createdName=ms9000000046672090, createdTime=Wed Feb 23 11:48:09 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015027, encodeId=0b7d101502e83, content=请教一下，editor invited 代表什么进度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5df92471731, createdName=Zero2326, createdTime=Mon Sep 06 12:54:06 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056322, encodeId=17ce1056322b8, content=有大神知道editor invited 2个星期，没有变化是什么意思？是没有editor愿意审稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Sep 29 23:47:17 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587461, encodeId=051d58e461fc, content=2月28号提交修过的稿，现在还在editor assigned 救救孩子吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/28/5f700d89db881251d21146123e7612c7.jpg, createdBy=04bb2384617, createdName=1231e470m09(暂无昵称), createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976161, encodeId=474e9e616182, content=开始记录：5月22日投稿，6月1日变为Under Review，6月6日状态未变，状态日期变为6月6日, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Wed Jun 23 11:37:17 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995445, encodeId=2912995445f7, content=7月2日：Reviews Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Fri Jul 02 17:27:24 CST 2021, time=2021-07-02, status=1, ipAttribution=)]

2020-03-26 1231e470m09(暂无昵称)

2月28号提交修过的稿，现在还在editor assigned 救救孩子吧

124 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2105004, encodeId=0b7121050040b, content=巨慢，投稿系统还持续不稳定。佛系期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f81975964, createdName=1e170646m17(暂无匿称), createdTime=Thu Dec 08 22:58:06 CST 2022, time=2022-12-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1195827, encodeId=17c4119582ebc, content=我也来记录一下：2022.1.17 Submit；1.18 Reviewers Assigned 然后一个月状态纹丝不动，这真好慢啊，持续等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220221/0d3bc24c99254010b05063bc9bca3c80/6249f4ad5757491b815f6696fe3077c8.jpg, createdBy=011a4698295, createdName=1165291396, createdTime=Mon Feb 21 20:58:21 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196349, encodeId=5aad11963494f, content=审稿速度:6.0 经验分享：2021年投稿一篇，记录一下自己的投稿历程： 20210913投稿；20多天后从reviewers invited变成reviewers assigned；之后状态经历多轮reviewers invited, reviewers assigned, under review的变化，发邮件询问得到的回复是找不到reviewers；又过了很久，终于在20220203收到major revision的修改意见；20220208修改后返回杂志社；20220213 状态变成review completed；20220220 状态最终变成Final Decision Accept。 谨以此记录经验互享，祝福各位大神！山高水远，江湖再见～ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Feb 23 10:40:47 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566137, encodeId=487b56613e78, content=兄弟您好。我也是做的甲基化和临床相关的生存预后。能中吗？您是搞基础的吗zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, beContent=zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160801/IMG579F60E036DF66469.jpg, createdBy=8b2b1931040, createdName=南医草民, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196372, encodeId=a2b611963e2be, content=文章赶紧接受吧，祈祷🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=510d5710114, createdName=ms9000000046672090, createdTime=Wed Feb 23 11:48:09 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015027, encodeId=0b7d101502e83, content=请教一下，editor invited 代表什么进度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5df92471731, createdName=Zero2326, createdTime=Mon Sep 06 12:54:06 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056322, encodeId=17ce1056322b8, content=有大神知道editor invited 2个星期，没有变化是什么意思？是没有editor愿意审稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Sep 29 23:47:17 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587461, encodeId=051d58e461fc, content=2月28号提交修过的稿，现在还在editor assigned 救救孩子吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/28/5f700d89db881251d21146123e7612c7.jpg, createdBy=04bb2384617, createdName=1231e470m09(暂无昵称), createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976161, encodeId=474e9e616182, content=开始记录：5月22日投稿，6月1日变为Under Review，6月6日状态未变，状态日期变为6月6日, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Wed Jun 23 11:37:17 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995445, encodeId=2912995445f7, content=7月2日：Reviews Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Fri Jul 02 17:27:24 CST 2021, time=2021-07-02, status=1, ipAttribution=)]

2021-06-23 ms3000000783425468

开始记录：5月22日投稿，6月1日变为Under Review，6月6日状态未变，状态日期变为6月6日

79 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2105004, encodeId=0b7121050040b, content=巨慢，投稿系统还持续不稳定。佛系期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3f81975964, createdName=1e170646m17(暂无匿称), createdTime=Thu Dec 08 22:58:06 CST 2022, time=2022-12-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1195827, encodeId=17c4119582ebc, content=我也来记录一下：2022.1.17 Submit；1.18 Reviewers Assigned 然后一个月状态纹丝不动，这真好慢啊，持续等待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220221/0d3bc24c99254010b05063bc9bca3c80/6249f4ad5757491b815f6696fe3077c8.jpg, createdBy=011a4698295, createdName=1165291396, createdTime=Mon Feb 21 20:58:21 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196349, encodeId=5aad11963494f, content=审稿速度:6.0 经验分享：2021年投稿一篇，记录一下自己的投稿历程： 20210913投稿；20多天后从reviewers invited变成reviewers assigned；之后状态经历多轮reviewers invited, reviewers assigned, under review的变化，发邮件询问得到的回复是找不到reviewers；又过了很久，终于在20220203收到major revision的修改意见；20220208修改后返回杂志社；20220213 状态变成review completed；20220220 状态最终变成Final Decision Accept。 谨以此记录经验互享，祝福各位大神！山高水远，江湖再见～ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Feb 23 10:40:47 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566137, encodeId=487b56613e78, content=兄弟您好。我也是做的甲基化和临床相关的生存预后。能中吗？您是搞基础的吗zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, beContent=zhaoyang123 2019-01-20 00:00:00 发表: 文章接受，祝福各位大神，再见了。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160801/IMG579F60E036DF66469.jpg, createdBy=8b2b1931040, createdName=南医草民, createdTime=Fri Jan 25 00:00:00 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196372, encodeId=a2b611963e2be, content=文章赶紧接受吧，祈祷🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=510d5710114, createdName=ms9000000046672090, createdTime=Wed Feb 23 11:48:09 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015027, encodeId=0b7d101502e83, content=请教一下，editor invited 代表什么进度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5df92471731, createdName=Zero2326, createdTime=Mon Sep 06 12:54:06 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056322, encodeId=17ce1056322b8, content=有大神知道editor invited 2个星期，没有变化是什么意思？是没有editor愿意审稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Wed Sep 29 23:47:17 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587461, encodeId=051d58e461fc, content=2月28号提交修过的稿，现在还在editor assigned 救救孩子吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/28/5f700d89db881251d21146123e7612c7.jpg, createdBy=04bb2384617, createdName=1231e470m09(暂无昵称), createdTime=Thu Mar 26 00:00:00 CST 2020, time=2020-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976161, encodeId=474e9e616182, content=开始记录：5月22日投稿，6月1日变为Under Review，6月6日状态未变，状态日期变为6月6日, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Wed Jun 23 11:37:17 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995445, encodeId=2912995445f7, content=7月2日：Reviews Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9a0b5502126, createdName=ms3000000783425468, createdTime=Fri Jul 02 17:27:24 CST 2021, time=2021-07-02, status=1, ipAttribution=)]

2021-07-02 ms3000000783425468

7月2日：Reviews Completed

68 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务